Testing a new platform to screen disease-modifying therapy in type 1 diabetes

by Sandra M. Lord, Henry T. Bahnson, Carla J. Greenbaum, David R. Liljenquist, John Virostko, Cate Speake
Published 2023-01-01

The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes.

by Allison J Greaney, Rachel T Eguia, Tyler N Starr, Khadija Khan, Nicholas Franko, Jennifer K Logue, Sandra M Lord, Cate Speake, Helen Y Chu, Alex Sigal, Jesse D Bloom
Published 2022-06-01